Eli Lilly (LLY) ACCELERATE Trial Proves 'Modestly Positive' for Esperion Therapeutics (ESPR) LDL Hypothesis - Stifel
Go back to Eli Lilly (LLY) ACCELERATE Trial Proves 'Modestly Positive' for Esperion Therapeutics (ESPR) LDL Hypothesis - Stifel| ESPERION THERAP (NASDAQ: ESPR) | Delayed: 3.18 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $30.41 | |||
| Open | $3.18 | 52 Week Low | $9.40 | |||
| Day High | $3.18 | P/E | N/A | |||
| Day Low | $3.18 | EPS | $-21.87 | |||
| Volume | 4,173,592 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1115.70 -7.3 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1123.00 | 52 Week High | $88.16 | |||
| Open | $1129.41 | 52 Week Low | $67.88 | |||
| Day High | $1131.44 | P/E | 258.26 | |||
| Day Low | $1113.29 | EPS | $4.32 | |||
| Volume | 1,837,997 | |||||
